Download Report

INSTANT reference on all the available Medicines
Mobile Application
How to Use Mobile Application
(Including Overview of Contents)
(Page 1 to 18)
After you download the Application, spare a
few minutes to read this “Manual” (Yellow
Pages). It will tell you how to access data
easily, quickly and smartly. You will know,
ultimately, the features and benefits of the
Application.
Start Here
Brief Overview of Contents of PharmaGuide Mobile Application
PharmaGuide Mobile Application contains comprehensive prescribing and trade information of all the
medicines in the country for which the Application is available [e.g. Afghanistan Edition contains
information on all medicines available in Afghanistan, Pakistan Edition contains information on all
medicines available in Pakistan]. PharmaGuide Mobile Application is automatically updated monthly
onto your Smartphone without any extra charges. All information including WHO/USFDA drug
prescribing information updates, new products, price changes etc are updated every month. This will
help the medical and allied profession to remain always updated to information on all medicines
available in their country.
The following information in the following order will appear whenever you will search information for any product:
Name of the Product
Company
Therapeutic Category: Appears in Black
Colour below product name.
4 Drug Category: (e.g. sulphonylurea,
biguanide….), if applicable, appears in Golden
Colour after the therapeutic category.
5 Generic Name/Contents: Appears in Purple
Colour after the therapeutic and drug category.
In case of products having large number of
ingredients (e.g. Centrum) complete formula of
the product appears.
6 Dosage Form & Strength of the relevant
product.
7 Pack Size & Retail Price: Will
appear only when Price Button is
Tapped. Re-tapping of this button will hide the
pack & price information i.e. always Tapping &
Re-tapping will show or hide the prices.
Risk Factors
1
rice
2
3
(1)
8
Information provided under Risk Factors include
Contraindications, Precautions and Risks in
Pregnancy & Lactation for the relevant product.
9
Dosage & Indications
10
For injectables, method of preparation and
administration are made crystal clear. The
diluent and their quantity are mentioned.
11
Interactions
12
Adverse Effects
Administration
Alternate Products
13
Search for an Alternative product having
SAME Content or SAME Drug Category
or SAME Therapeutic Category.
(2)
Explanation of the Buttons that has been used in the PharmaGuide Mobile Application:
PharmaGuide
Forward &
Backward
Search PharmaGuide
Type your search here...
X
Tap “Yellow Button”
to Go to Search Screen
Tapping option menu will show you the
following information:
Search
Risk Factors
Tap XX
to clear
the text
PharmaGuide data is update-to-date.
Refined Specific
Search Colour
Buttons. These
buttons may or
may not be
used because all
information, can
simply be seen
by SCROLLING
the Screen.
Dosage & Indications
Upgrade to complete Data
You are using Data on Cephalosporins only
Administration
Interactions
Adverse Effects
Help
Check for data updates
(Last Updated December 22, 2012)
Visit epharmaguide.com
Exit Application
Alternate Products
rice
Price will appear only when “PRICE Button” is
Tapped. Tapping & Re-tapping will show or hide
the prices.
rand
While Scrolling Tap “Black Button”
to Go to Top of the Screen
Tapping of this “BRAND Button”, will show you a
list of Brands which are available for the Generic.
(3)
You are registered with Email
To maintain continuity of services
update the data every month
(4)
Tap 'product icon' to start application
and to go to search screen.
Search Screen (Main Screen)
This is the Main Screen and is to be used
most frequently. This screen is mainly used
to find information on any product.
The user must be smart or well versed in
using this screen. It is extremely important
if the user wants to find and make use of
the benefits of information provided in the
PharmaGuide Mobile Application.
You can at any time tap X
to clear the text in the box
PharmaGuide
Search PharmaGuide
Type your search here...
X
Please type text in search box
Brand Name
The User can go to this Search screen at any
moment by tapping this “Yellow Button”
How to Use this Search Screen:
When this screen appears, Tap Search Box
Area, Key board appears.
Type text to find detail information on the
next screen. As you Type text, a list below
will appear, you can also tap any one to go
to next screen to see the detail information.
Generic Name (e.g. Cefoperazone)
Contents
(e.g. Cefoperazone and Sulbactam)
Therapeutic Category
(e.g. Cephalosporins)
IMPORTANT: You have to type ONLY any of
these four options i.e. (1). Brand Name (2).
Generic Name (3). Contents (4). Therapeutic
Category. Other than these four types of
information never type any other
information for finding any information.
(5)
(6)
As you type the text in the box of “Search Screen” the list below will show you
in the following manner:
When list appears
Magenta bullet before a line indicates a
Brand Name
Ace
X
ACE Inhibitors
Purple bullet before a line indicates
Generic Name and/or Contents
Black bullet before a line indicates a
Therapeutic Category
Ace-Bex
Aceartin
Aceclofenac
As you tap any item you will find detail
information on the next screen.
(7)
Acef
(8)
Hypoglycaemics excluding Insulins
Sulphonylurea
Glimepiride
Tab 1 mg; 2 mg; 3 mg; 4 mg.
Tab 1 mg 2x10’s: Rs.55.00
Tab 2 mg 2x10’s: Rs.97.00
Tab 3 mg 2x10’s: Rs.170.00
Tab 4 mg 2x10’s: Rs.215.00
rice
On typing or tapping a Brand Name, you will find information in the following order,
colour and style. Scrolling of the screen will always allow you to see the continuing information.
Glemex Schazoo Zaka
At any time, you may tap
“Yellow Button” to go to
Search Screen and search
for any other product.
nly
l appear o
PRICE wil
Button
e
c
i
r
P
en
wh
ing
. Re-tapp
is Tapped
rices
p
e
h
t
e
d
i
will h
RISK FACTORS:
Pregnancy: Contraindicated in pregnancy.
Lactation: Contraindicated or not recommended.
Contra-ind: Insulin-dependant (type 1) diabetes mellitus; diabetic ketoacidosis; diabetic precoma or coma; hypersensitivity to
glimepiride or other sulfonylureas or sulfonamides; serious renal or hepatic dysfunction; dialysis patients.
Precautions: Regular monitoring of glucose levels in blood and urine. Milder or absent symptoms of hypoglycaemia, e.g. in patients
with autonomic neuropathy or taking beta blockers, clonidine, reserpine, guanethidine or other sympatholytic drugs. Temporary
change over to insulin in exceptional stress situations (e.g. trauma, surgery, infections with fever).
DOSAGE (Alongwith Indications):
Non-insulin-dependant (type 2) diabetes mellitus.
Adults: Usual initial dosage 1 mg once daily; daily dosage may be increased at intervals of 1-2 weeks and carried out stepwise as
follows: 1 mg, 2 mg, 3 mg, 4 mg, 6 mg and in exceptional cases 8 mg. Usual maintenance dose 1 mg to 4 mg daily. Children: Not
recommended.
ADMINISTRATION
--INTERACTIONS
Insulin, oral antidiabetics, ACE-inbibitors, allopurinol, anabolic steroids and male sex hormones, probenicid, quinolones, salicylates,
sulfinpyrazone, sulfonamides, tetracyclines, tritoqualine, trofosfamide, barbiturates, corticosteroids, diazoxide, diuretics,
epinephrine and other sympathomimetic agents, glucagon, laxatives, nicotinic acid (in high doses), oestrogens, phenothiazines,
phenytion, rifampicin, thyroid hormones, H2-receptor antagonists, clonidine, reserpine; acute & chronic alcohol intake.
ADVERSE EFFECTS
Hypoglycaemia, signs of adrenergic counterregulation, hepatitis, liver failure, thromobocytopenia, heamolytic anaemia.
(9)
( 10 )
Ceftriaxone
Cephalosporins
Inj 250 mg; 500 mg; 1 gm; 2 gm.
rand
On typing or tapping a Generic (and/or Content) Name, you will find information in the
following order, colour and style. Scrolling of the screen will always allow you to see the continuing information.
AND”
f this “BR
st
Tapping o
w you a li
o
sh
ll
i
w
,
le
Button
are availab
h
ic
h
w
s
of Brand
eric.
en
G
e
th
for
RISK FACTORS:
Pregnancy: No evidence of risk in humans.
Lactation: Caution advised or effect undetermined.
Contra-ind: Beta-Iactam hypersensitivity. Premature newborns having less than 41 weeks postmenstrual age;
neonates over 41 weeks postmenstrual age with jaundice, hypoalbuminaemia or acidosis; concomitant treatment
with IV calcium (including total parenteral nutrition containing calcium) in neonates over 41 weeks postmenstrual
age - risk of precipitation in urine and lung. Do not use in hyperbilirubinemia neonates.
Precautions: Severe renal and hepatic impairment. Do not use in pregnancy unless absolutely indicted.
DOSAGE: (Alongwith Indications)
Severe respiratory and genitourinary tract, bone and joint, abdominal infections, sepsis, meningitis.
Adults: Usually 1 gm daily by deep IM., slow IV inj over at least 2-4 mins., or IV infusion. Severe infections, 2-4 gm
as a single dose every 24 hours. Children: Usually 20-50 mg/kg once daily by IM inj., slow IV inj over at least 2-4
mins., or IV infusion. Severe infections, up to maximum 80 mg/kg daily (maximum 50 mg/kg in neonates). Doses
over 50 mg/kg to be given by slow IV infusion over at least 30 minutes.
Peri-op prophylaxis: Adults: 1 gm as single IM or slow IV dose.
Colorectal surgery: Adults: 2 gm by IM, slow IV inj or infusion with anaerobic antibacterial.
Lower Respiratory Infection: Adults: IM/IV: Usual: 1-2 gm once daily (or in equally BID doses). Max: 4 gm/day.
Otitis Media: Children: 50 mg/kg IM single dose. Max: 1 gm/dose.
Bone Infection: Adult: IM/IV: Usual:1-2 gm once daily (or in equally BID doses). Max: 4 gm/day. Meningitis: IV:
Adults: 1-2 gm once daily (or in equally BID doses). Max: 4 gm/day. Children: Initial of 100 mg/kg (not to exceed 4
gm), then 100 mg/kg once daily or (in equally BID doses) for 7-14 days. Max: 4 gm/day.
Septicaemia: IV: Adults: 1-2 gm once daily (or in equally BID doses). Max: 4 gm/day. Children: 50-75 mg/kg in
divided doses every 12 hours. Max: 2 gm/day.
Urinary Tract Infection: Adults: IM/IV: 1-2 gm once daily (or in equally BID doses). Max: 4 gm/day.
Gonorrhoea: Single dose of 250 mg by IM inj.
(Continued on Next Page.....)
( 11 )
( 12 )
ADMINISTRATION:
Ceftriaxone may be administered by IV intermittent infusion over 10-30 min; final concentration for IV
administration should not exceed 40 mg/mL. The drug has also been administered by direct IV push over 2-4 min.
Inject deep IM into large muscle mass.
IM Injection: 250 mg/500 mg/1000 mg VIAL: To make concentration of 250 mg/mL add Water for Injection 0.9
mL in 250 mg vial; 1.8 mL in 500 mg vial; 3.6 mL in 1000 mg vial.
IV: 250 mg/500 mg/1000 mg VIAL: To make concentration of 100 mg/mL add Water for Injection 2.4 mL in 250
mg vial; 4.8 mL in 500 mg vial; 9.6 mL in 1000 mg vial.
Compatibility: Stable in D5W with KCL 10 mEq, D5W, D10W, NS, mannitol 5%, mannitol 10%, Sodium bicarbonate
5%, bacteriostatic water,SWFI.
Stability: For IV infusion in NS or D5W, solution is stable for 3 days at room temperature or 10 days when
refrigerated.
INTERACTIONS:
Oral contraceptives, calcium containing IV solns.
ADVERSE EFFECTS:
GI upset. skin reactions, blood dyscrasias. Rarely pseudomembranous colitis, raised liver enzymes, glucosuria,
oliguria, haematuria, bronchospasm, phlebitis at inj. site, urinary and biliary precipitates, pancreatitis.
PharmaGuide
Ceftriaxone
rand
Ceftriaxone
Aczon
Adjex
You can tap any item on
the List to see the detail
information of the Brand.
Scrolling will show further
product in the list.
You can also type brand
name in the box to find
products that contains the
Albaxon
same Generic.
Cephalosporins
Inj 250 mg; 500 mg; 1 gm; 2 gm.
Type for Brand.....
Acmex
X
Alexon
( 13 )
( 14 )
An Outstanding benefit of PharmaGuide Mobile Application:
Find Alternate Products within SECONDS. Just Tap the Green Button
Three different features for finding alternative products have been provided. You can use any
of these three feature by simply tapping the “GREEN BUTTON”
1) Search for an Alternative product having SAME Content.
2) Search for an Alternative product having SAME Drug Category.
3) Search for an Alternative product having SAME Therapeutic Category.
1) To Search for an Alternative of Amaryl having SAME
Content.
Amaryl Contains Glimepiride.
Tap Glimepiride to find other products containing
Glimepiride
2) To Search for an Alternative of Amaryl having SAME
Drug Category.
Amaryl Drug Category is Sulphonylurea.
Tap Sulphonylurea to find other products containing
Sulphonylurea
PharmaGuide
Amaryl
Amaryl Sanofi Aventis
Hypoglycaemics excluding Insulins
Sulphonylurea
Glimepiride
Tab 1 mg; 2 mg; 3 mg; 4 mg.
ALTERNATIVES
Glimepriride Sulphonylurea Hypoglycaem...
Type for Brand.....
X
Amarit
3) To Search for an Alternative of Amaryl having SAME
Therapeutic Category.
Amaryl Therapeutic Category is Hypoglycaemics.
Tap Hypoglycaemics to find other Hypoglycaemics
Amaryl
Bamaryl
Tap any item on the list to see its detail information.
( 15 )
rice
e.g. Searching for an Alternative of Amaryl:
When you are seeing information of Amaryl,
Tap the “GREEN BUTTON”, this screen
will appear. Then “TAP” any of the three “BOXES”.
( 16 )
Optional or Additional feature for Refined Specific Search
For Refined Specific Search different Colour Buttons as shown below are provided. These buttons
may or may not be used because all information, can simply be seen by SCROLLING the Screen.
For example if Magenta Button is Tapped, Interactions of the product will appear on the next screen.
PharmaGuide
Glemex
Glemex Schazoo Zaka
Hypoglycaemics excluding Insulins
Sulphonylurea
Glimepiride
Tab 1 mg; 2 mg; 3 mg; 4 mg.
RISK FACTORS:
Pregnancy: Contraindicated in pregnancy.
Lactation: Contraindicated or not
recommended.
Contra-ind: Insulin-dependant (type 1)
diabetes mellitus; diabetic ketoacidosis;
diabetic precoma or coma; hypersensitivity to
glimepiride or other sulfonylureas or
sulfonamides; serious renal or hepatic
dysfunction; dialysis patients.
Precautions: Regular monitoring of glucose
levels in blood and urine. Milder or absent
symptoms of hypoglycaemia, e.g. in patients
with autonomic neuropathy or taking beta
blockers, clonidine, reserpine, guanethidine or
other sympatholytic drugs. Temporary change
over to insulin in exceptional stress situations
(e.g. trauma, surgery, infections with fever).
Tap any of the
following colour buttons
for specific search
Risk Factors
Dosage &
Indications
Administration
Interactions
PharmaGuide
Glemex
Glemex Schazoo Zaka
Hypoglycaemics excluding Insulins
Sulphonylurea
Glimepiride
Tab 1 mg; 2 mg; 3 mg; 4 mg.
INTERACTIONS
Insulin, oral antidiabetics, ACE-inbibitors,
allopurinol, anabolic steroids and male sex
hormones, probenicid, quinolones, salicylates,
sulfinpyrazone, sulfonamides, tetracyclines,
tritoqualine, trofosfamide, barbiturates,
corticosteroids, diazoxide, diuretics,
epinephrine and other sympathomimetic
agents, glucagon, laxatives, nicotinic acid (in
high doses), oestrogens, phenothiazines,
phenytion, rifampicin, thyroid hormones, H2receptor antagonists, clonidine, reserpine;
acute & chronic alcohol intake.
Adverse
Effects
DOSAGE (Alongwith Indications):
Non-insulin-dependant (type 2) diabetes
mellitus.
( 17 )
( 18 )